Skip to main content
Jason Cheng-Hsuan Chiang, MD, PhD
Jason Cheng-Hsuan Chiang, MD, PhD

Jason Cheng-Hsuan Chiang, MD, PhD

Associate Member, St. Jude Faculty

Departments

Education

PhD – Johns Hopkins University School of Medicine, Baltimore, Maryland
MD – National Taiwan University School of Medicine, Taipei, Taiwan

Honors & Awards

  • 2024 Society for Neuro-Oncology Annual Meeting Keynote Speaker
  • 2023 Top Cited Article in Brain Pathology 2021- 2022
  • 2015 American Association of Neuropathologists Travel Award
  • 2015 Pathology Postdoctoral Research Training Program Award, University of Pittsburgh School of Medicine Department of Pathology
  • 2010 Maryland Stem Cell Research Fund Post-Doctoral Fellowship
  • 2009 American Heart Association Predoctoral Fellowship
  • 2005 Taiwan Merit Scholarship

Research Interests

  • Diagnosis and classification of pediatric central nervous system neoplasms
  • Molecular drivers and markers of pediatric central nervous system neoplasms

Selected Publications

Gorodezki D, Chiang J, Viaene AN, Sievers P, Schmid S, Holzer U, Paulsen F, Schuhmann MU, Witt O, Schittenhelm J, Ebinger M. A multi-institutional series of a novel, recurrent TRIM24::MET fusion-driven infant-type hemispheric glioma reveals significant clinico-pathological heterogeneity. Acta Neuropathol Commun. 2024 Jun 21;12(1):101. doi: 10.1186/s40478-024-01817-9.

Zuckermann M, He C, Andrews J, Bagchi A, Sloan-Henry R, Bianski B, Xie J, Wang Y, Twarog N, Onar-Thomas A, Ernst KJ, Yang L, Li Y, Zhu X, Ocasio JK, Budd KM, Dalton J, Li X, Chepyala D, Zhang J, Xu K, Hover L, Roach JT, Chan KC, Hofmann N, McKinnon PJ, Pfister SM, Shelat AA, Rankovic Z, Freeman BB 3rd, Chiang J, Jones DTW, Tinkle CL, Baker SJ. Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy. Mol Cancer. 2024 Jun 7;23(1):123. doi: 10.1186/s12943-024-02027-6

Moreira DC, Qaddoumi I, Spiller S, Bouldin TW, Davidson A, Saba-Silva N, Sullivan DV, Tanaka R, Wagner AS, Wood M, Klimo P, Job G, Devidas M, Li X, Gajjar A, Robinson GW, Chiang J. Comprehensive analysis of MYB/MYBL1-altered pediatric-type diffuse low-grade glioma. Neuro Oncol. 2024 Mar 11:noae048. doi: 10.1093/neuonc/noae048

Ibanez J, Hebbar N, Thanekar U, Yi Z, Houke H, Ward M, Nevitt C, Tian L, Mack SC, Sheppard H, Chiang J, Velasquez MP, Krenciute G. GRP78-CAR T cell effector function against solid and brain tumors is controlled by GRP78 expression on T cells. Cell Rep Med. 2023 Nov 21;4(11):101297. doi: 10.1016/j.xcrm.2023.101297 

Chiang J, Bagchi A, Li X, Dhanda SK, Huang J, Pinto SN, Sioson E, Dalton J, Tatevossian RG, Jia S, Partap S, Fisher PG, Bowers DC, Hassall TEG, Lu C, Zaldivar-Peraza A, Wright KD, Broniscer A, Qaddoumi I, Upadhyaya SA, Vinitsky A, Sabin ND, Orr BA, Klimo P Jr, Boop FA, Ashford JM, Conklin HM, Onar-Thomas A, Zhou X, Ellison DW, Gajjar A, Robinson GW. High-grade glioma in infants and young children is histologically, molecularly, and clinically diverse: Results from the SJYC07 trial and institutional experience. Neuro Oncol Jan 5;26(1):178-190, 2024. doi: 10.1093/neuonc/noad130

Li X, Moreira DC, Bag AK, Qaddoumi I, Acharya S, Chiang J. The clinical and molecular characteristics of progressive hypothalamic/optic pathway pilocytic astrocytoma. Neuro Oncol Apr 6;25(4):750-760, 2023. doi: 10.1093/neuonc/noac241

Chiang J, Moreira DC, Li X, Furtado LV. Prognostic significance of chromosome arm 1q gain and methylation class in molecularly defined diffuse leptomeningeal glioneuronal tumor. Acta Neuropathol Dec;144(6):1185-1187, 2022. doi: 10.1007/s00401-022-02507-3

Flasch DA, Chen X, Ju B, Li X, Dalton J, Mulder HL, Easton J, Wang L, Baker SJ, Chiang J*, Zhang J*. Somatic LINE-1 promoter acquisition drives oncogenic FOXR2 activation in pediatric brain tumor. Acta Neuropathol May;143(5):605-607, 2022. doi: 10.1007/s00401-022-02420-9. *Co-corresponding authors

Chiang J, Moreira DC, Pytel NJ, Liu YC, Blackburn PR, Shi Z, Cardenas M, Wheeler DA, Furtado LV. A CTNNB1-altered medulloblastoma shows the immunophenotypic, DNA methylation, and transcriptomic profiles of SHH-activated, and not WNT-activated, medulloblastoma. Neuropathol Appl Neurobiol Mar 23, 2022. doi: 10.1111/nan.12815

Chiang J, Li X, Jin H, Wu G, Lin T, Ellison DW. The molecular characteristics of low-grade and high-grade areas in desmoplastic infantile astrocytoma/ ganglioglioma. Neuropathol Appl Neurobiol Feb 21, 2022. DOI: 10.1111/nan.12801

He C, Xu K, Zhu X, Dunphy PS, Gudenas B, Lin W, Twarog N, Hover LD, Kwon CH, Kasper LH, Zhang J, Li X, Dalton J, Jonchere B, Mercer KS, Currier DG, Caufield W, Wang Y, Xie J, Broniscer A, Wetmore C, Upadhyaya SA, Qaddoumi I, Klimo P, Boop F, Gajjar A, Zhang J, Orr BA, Robinson GW, Monje M, Freeman Iii BB, Roussel MF, Northcott PA, Chen T, Rankovic Z, Wu G, Chiang J*, Tinkle CL*, Shelat AA*, Baker SJ*. Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma. Nat Commun 12(1):4089, 2021. *Co-corresponding authors

Haydar D, Houke H, Chiang J, Yi Z, Odé Z, Caldwell K, Zhu X, Mercer KS, Stripay JL, Shaw TI, Vogel P, DeRenzo C, Baker SJ, Roussel MF, Gottschalk S, Krenciute G. Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery. Neuro Oncol 23(6):999-1011, 2021.

Keenan C, Graham RT, Harreld JH, Lucas JT Jr, Finkelstein D, Wheeler D, Li X, Dalton J, Upadhyaya SA, Raimondi SC, Boop FA, DeCuypere M, Zhang J, Vinitsky A, Wang L, Chiang J. Infratentorial C11orf95-fused gliomas share histologic, immunophenotypic, and molecular characteristics of supratentorial RELA-fused ependymoma. Acta Neuropathol 140(6):963-965, 2020.

Chiang J, Diaz AK, Makepeace L, Li X, Han Y, Li Y, Klimo P Jr, Boop FA, Baker SJ, Gajjar A, Merchant TE, Ellison DW, Broniscer A, Patay Z, Tinkle CL. Clinical, imaging, and molecular analysis of pediatric pontine tumors lacking characteristic imaging features of DIPG. Acta Neuropathol Commun 8(1):57, 2020. 

Chiang J, Li X, Liu APY, Qaddoumi I, Acharya S, Ellison DW. Tectal glioma harbors high rates of KRAS G12R and concomitant KRAS and BRAF alterations. Acta Neuropathol 39(3):601-602, 2020.

Sievers P, Chiang J, Schrimpf D, Stichel D, Paramasivam N, Sill M, Gayden T, Casalini B, Reuss DE, Dalton J, Pajtler KW, Hänggi D, Herold-Mende C, Rushing E, Korshunov A, Mawrin C, Weller M, Schlesner M, Wick W, Jabado N, Jones DTW, Pfister SM, von Deimling A, Ellison DW, Sahm F. YAP1-fusions in pediatric NF2-wildtype meningioma. Acta Neuropathol 139(1):215-218, 2020.

Carey SS, Sadighi Z, Wu S, Chiang J, Robinson GW, Ghazwani Y, Liu APY, Acharya S, Merchant TE, Boop FA, Gajjar A, Qaddoumi I. Evaluating pediatric spinal low-grade gliomas: a 30-year retrospective analysis. J Neurooncol 145(3):519-529, 2019.

Chiang J, Harreld JH, Tinkle CL, Moreira DC, Li X, Acharya S, Qaddoumi I, Ellison DW. A single-center study of the clinicopathologic correlates of gliomas with a MYB or MYBL1 alteration. Acta Neuropathologica 138(6):1091-1092, 2019.

Chiang J, Harreld JH, Tanaka R, Li X, Wen J, Zhang C, Boué DR, Rauch TM, Boyd JT, Chen J, Corbo JC, Bouldin TW, Elton SW, Liu LL, Schofield D, Lee SC, Bouffard JP, Georgescu MM, Dossani RH, Aguiar MA, Sances RA, Saad AG, Boop FA, Qaddoumi I, Ellison DW. Septal dysembryoplastic neuroepithelial tumor: a comprehensive clinical, imaging, histopathologic, and molecular analysis. Neuro-Oncology 21(6):800-808, 2019.

Heitzer AM, Ashford JM, Hastings C, Liu APY, Wu S, Bass JK, Vestal R, Hoehn M, Chiang J, Ghazwani Y, Acharya S, Boop F, Gajjar A, Merchant TE, Qaddoumi I, Conklin HM.  Neuropsychological outcomes of patients with low-grade glioma diagnosed during the first year of life. Journal of Neuro-Oncology 141(2):413-420, 2019.

Chiang J, Dalton J, Upadhyaya SA, Patay Z, Qaddoumi I, Li X, Segura AD, Sharma S, Ismail A, Shurtleff SA, Raimondi SC. Chromosome arm 1q gain is an adverse prognostic factor in localized and diffuse leptomeningeal glioneuronal tumors with BRAF gene fusion and 1p deletion. Acta Neuropathologica 137(1):179-181, 2019.

Xu K, Ding L, Chang TC, Shao Y, Chiang J, Mulder H, Wang S, Shaw TI, Wen J, Hover L, McLeod C, Wang YD, Easton J, Rusch M, Dalton J, Downing JR, Ellison DW, Zhang J, Baker SJ, Wu G. Structure and evolution of double minutes in diagnosis and relapsebrain tumors. Acta Neuropathologica 137(1):123-137, 2019.

Liu APY, Harreld JH, Jacola LM, Gero M, Acharya S, Ghazwani Y, Wu S, Li X, Klimo P, Gajjar A, Chiang J, Qaddoumi I. Tectal glioma as a distinct diagnostic entity:a comprehensive clinical, imaging,histologic and molecular analysis. Acta Neuropathologica Communications  6:101, 2018.

Deng MY, Sill M, Chiang J, Schittenhelm J, Ebinger M, Schuhmann MU, Monoranu CM, Milde T, Wittmann A, Hartmann C, Sommer C, Paulus W, Gärtner J, Brück W, Rüdiger T, Leipold A, Jaunmuktane Z, Brandner S, Giangaspero F, Nozza P, Mora J, Morales la Madrid A, Cruz Martinez O, Hansford JR, Pietsch T, Tietze A, Hernáiz-Driever P, Stoler I, Capper D, Korshunov A, Ellison DW, von Deimling A, Pfister SM, Sahm F, Jones DTW.  Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features. Acta Neuropathologica 136(2):239-253, 2018.  

Ghazwani Y, Qaddoumi I, Bass JK, Wu S, Chiang J, Boop F, Gajjar A, Sadighi Z (2017) Profound hearing loss following surgery in pediatric patients with posterior fossa low-grade glioma. Neuro-Oncology Practice Dec 18, 2017.

Chiang CH, Harreld JH, Orr BA, Sharma S, Ismail A, Segura AD, Ellison DW. Low-grade spinal glioneuronal tumors with BRAF gene fusion and 1p deletion but without leptomeningeal dissemination. Acta Neuropathologica July;134(1):159-62, 2017.

Chiang CH, Ellison DW. Molecular Pathology of Pediatric Central Nervous System Tumors. Journal of Pathology Jan; 241(2):159-172, 2017.

Bissel SJ, Auer R, Chiang CH, Kofler J, Murdoch GH, Nix WA, Painter M, Richer M, Startelet H, Wang G, Wiley CA. Human Parechovirus 3 Meningitis and Fatal Leukoencephalopathy. Journal of Neuropathology & Experimental Neurology Aug;74(8):767-77, 2015.

Chiang CH, Chu CT, Wiley CA. A 67 Year-Old Man with Multiple Sclerosis and New Cerebellar Lesions. Brain Pathol Jul;25(4):507-8, 2015.

Wen Z, Nguyen HN, Guo Z, Lalli MA, Wang X, Su Y, Kim NS, Yoon KJ, Shin J, Zhang C, Makri G, Nauen D, Yu H, Guzman E, Chiang CH, Yoritomo N, Kaibuchi K, Zou J, Christian KM, Cheng L, Ross CA, Margolis RL, Chen G, Kosik KS, Song H, Ming GL. Synaptic dysregulation in a human iPS cell model of mental disorders. Nature Nov 20;515(7527):414-8, 2014

Wang HC, Lu CH, Cheng KI, Chiang CH. Inflammatory reaction in neurological diseases. Biomed Res Int 2014:408514, 2014.

HD iPSC Consortium. Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes. Cell Stem Cell 11(2):264-78, 2012.

Juopperi TA, Kim WR, Chiang CH, Yu H, Margolis RL, Ross CA, Ming GL, Song H. Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells. Molecular Brain 5(1):17-30, 2012.

Chiang CH, Su Y, Wen Z, Yoritomo N, Ross CA, Margolis RL, Song H, Ming GL. Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation. Mol Psychiatry Apr;16(4):358-60, 2011. Epub 2011 Feb 22. Cover of the issue.

Ma DK, Chiang CH, Ponnusamy K, Ming GL, Song H. G9a and Jhdm2a regulate embryonic stem cell fusion-induced reprogramming of adult neural stem cells. Stem Cells 26(8):2131-41, 2008. Epub 2008 Jun 5.

Chao CC, Chiang CH, Ma YL, Lee EH. Molecular mechanism of the neurotrophic effect of GDNF on DA neurons: role of protein kinase CK2. Neurobiology of Aging 27(1):105-18, 2006.

Last update: June 2024

Close